Acadia Healthcare Inc Revenue Growth Rates (ACHC), Current and Historic Growth - CSIMarket
CSIMarket
 


Acadia Healthcare Company Inc   (NASDAQ: ACHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

ACHC's Revenue Growth by Quarter and Year

Acadia Healthcare Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ACHC/growth
https://api.csimarket.com/api/v1/companies/ACHC/fundamentals
https://api.csimarket.com/api/v1/companies/ACHC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ACHC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 895.31
2nd Quarter June 865.84
1st Quarter March 828.80
FY 2,589.95

ACHCs Annual Revenue
Acadia Healthcare Inc 's Revenue in the fiscal year 2025 $ 3,312.77 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2024 $ 3,153.96 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2023 $ 2,928.74 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2022 $ 2,725.62 millions
Acadia Healthcare Inc 's Revenue in the fiscal year 2021 $ 2,454.56 millions




ACHC Revenue third quarter 2026 Y/Y Growth Comment
Acadia Healthcare Company Inc reported Revenue growth of 5.14% year on year in the third quarter 2026, to $ 895.31 millions, this is lower than Acadia Healthcare Company Inc 's recent average Revenue surge of 217.22%.

Looking into third quarter 2026 results within Healthcare Facilities industry 13 other companies have achieved higher Revenue growth. While Acadia Healthcare Company Inc ' s Revenue increase of 5.14% ranks overall at the positon no. 1991 in the third quarter 2026.




ACHC Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 5.14 %
2nd Quarter June -0.39 %
1st Quarter March 7.57 %
FY   -

Financial Statements
Acadia Healthcare Inc 's third quarter 2026 Revenue $ 895.31 millions ACHC's Income Statement
Acadia Healthcare Inc 's third quarter 2025 Revenue $ 851.57 millions Quarterly ACHC's Income Statement


ACHC Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.4 %
2nd Quarter June 4.47 %
1st Quarter March 0.89 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #14
Healthcare Sector #302
Overall #1991

Revenue Y/Y Growth Statistics
High Average Low
3459.26 % 217.22 % -100 %
(Dec 31 2018)   (March 31, 2015)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #14
Healthcare Sector #302
Overall #1991
Revenue Y/Y Growth Statistics
High Average Low
3459.26 % 217.22 % -100 %
(Dec 31 2018)   (March 31, 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Acadia Healthcare Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3315.3 % 147.3 % -100 %
(Jun 30 2018)  


ACHC's III. Quarter Q/Q Revenue Comment
Acadia Healthcare Company Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.4% quarter on quarter, to $ 895.31 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -2.03% in the III. Quarter a year ago.

Within Healthcare Facilities industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Acadia Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 1506.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #20
Healthcare Sector #198
Overall #1506
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #20
Healthcare Sector #198
Overall #1506
Revenue Q/Q Growth Statistics
High Average Low
3315.3 % 147.3 % -100 %
(Jun 30 2018)  


ACHC's III. Quarter Q/Q Revenue Comment
Acadia Healthcare Company Inc achieved in the III. Quarter 2026 below company average Revenue growth of 3.4% quarter on quarter, to $ 895.31 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -2.03% in the III. Quarter a year ago.

Within Healthcare Facilities industry 19 other companies have achieved higher Revenue quarter on quarter growth. While Acadia Healthcare Inc 's Revenue growth quarter on quarter, overall rank is 1506.


Acadia Healthcare Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 3,367.67
Y / Y Revenue Growth (TTM) 4.27 %
Year on Year Revenue Growth Overall Ranking # 1777
Seqeuential Revenue Change (TTM) -0.1 %
Seq. Revenue Growth (TTM) Overall Ranking # 2451


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Acadia Healthcare Inc 's cumulative twelve months Revenue were $ 3,368 millions, company would post below average annual Revenue growth of -0.1% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Acadia Healthcare Inc 's Revenue growth from the 865.84% growth in Mar 31 2026.

In the Healthcare sector 281 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1150 to 1777.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 282
Overall # 1777

Revenue TTM Y/Y Growth Statistics
High Average Low
3793.83 %
129.6 %
-309 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 358
S&P 500 # 2451
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Acadia Healthcare Inc 's cumulative twelve months Revenue were $ 3,368 millions, company would post below average annual Revenue growth of -309% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Acadia Healthcare Inc 's Revenue growth from the 865.84% growth in Mar 31 2026.

In the Healthcare sector 281 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1150 to 1777.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 25
Healthcare Sector # 282
Overall # 1777

Revenue TTM Y/Y Growth Statistics
High Average Low
3793.83 %
129.6 %
-309 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 358
S&P 500 # 2451




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ACHC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Encompass Health Corporation8.93%$ 8.934 millions
West Pharmaceutical Services Inc 8.73%$ 8.728 millions
Resmed Inc 8.67%$ 8.667 millions
Carlisle Companies Incorporated8.65%$ 8.649 millions
Concentra Group Holdings Parent Inc 8.61%$ 8.611 millions
Merit Medical Systems Inc8.56%$ 8.563 millions
Medpace Holdings Inc 8.50%$ 8.501 millions
Pulmonx Corporation8.47%$ 8.470 millions
Amgen Inc 8.45%$ 8.455 millions
Precipio inc 8.33%$ 8.335 millions
Fulgent Genetics Inc 8.26%$ 8.262 millions
Amphastar Pharmaceuticals Inc 8.22%$ 8.219 millions
Ultragenyx Pharmaceutical Inc 8.17%$ 8.170 millions
Baxter International Inc 8.08%$ 8.078 millions
Tactile Systems Technology Inc 8.07%$ 8.067 millions
Iqvia Holdings Inc 8.00%$ 8.000 millions
Exagen Inc 7.86%$ 7.859 millions
Gyre Therapeutics Inc 7.75%$ 7.754 millions
Stryker Corp7.64%$ 7.644 millions
Bausch and Lomb Corp7.34%$ 7.338 millions
Addus Homecare Corp7.19%$ 7.193 millions
Pacific Biosciences Of California Inc 7.03%$ 7.026 millions
Bristol myers Squibb Company6.93%$ 6.930 millions
Labcorp Holdings Inc 6.92%$ 6.917 millions
Gilead Sciences Inc 6.83%$ 6.835 millions
Arcturus Therapeutics Holdings Inc 6.68%$ 6.682 millions
National Healthcare Corp6.61%$ 6.614 millions
Tenet Healthcare Corp6.47%$ 6.466 millions
Phibro Animal Health Corporation6.32%$ 6.320 millions
Mettler toledo International Inc 6.27%$ 6.273 millions


About Acadia Healthcare Inc Revenue Growth Rates (ACHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Acadia Healthcare Company Inc (CIK 1520697).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-447412
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Acadia Healthcare Company Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.